<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid/><all-ids><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcid">PMC11063818</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcid-ver">PMC11063818.1</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcaid">11063818</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcaiid">11063818</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmid">38565289</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="doi">10.1523/JNEUROSCI.0538-23.2024</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="publisher-id">jneuro-44-e0538232024</article-id></all-ids><extracted-table><table-id>T1</table-id><table-label>Table 1.</table-label><table-caption>Participants’ characteristics</table-caption><table-wrap-foot>Data are presented as mean values followed by (standard deviations). Demographic and clinical variables were compared between groups using ANOVA or χ2 tests. CU, cognitively unimpaired; MCI, mild cognitive impairment; APOE ε4, apolipoprotein E ε4 allele; ADAS, Alzheimer's Disease Assessment Scale–Cognitive Subscale; VOSP, Visual Object and Space Perception Battery; TMT (B–A), trail making test Part B–A; SUVR, standardized uptake value ratio. Note that a higher ADAS score indicates poor memory performance.</table-wrap-foot><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" position="float" id="T1" orientation="portrait"><label>Table 1.</label><caption><p>Participants’ characteristics</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="left" span="1"/></colgroup><thead valign="bottom"><tr><th align="left" rowspan="2" colspan="1"/><th align="left" rowspan="1" colspan="1">Aβ-negative CU</th><th align="left" rowspan="1" colspan="1">Aβ-positive CU</th><th align="left" rowspan="1" colspan="1">Aβ-positive MCI</th><th align="left" rowspan="2" colspan="1">Statistic</th></tr><tr><th align="left" rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 224</th><th align="left" rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 91</th><th align="left" rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 78</th></tr></thead><tbody valign="top"><tr><td rowspan="2" colspan="1">Age</td><td rowspan="2" colspan="1">65.41 (9.74)</td><td rowspan="2" colspan="1">69.97 (8.59)</td><td rowspan="2" colspan="1">71.97 (6.44)</td><td rowspan="1" colspan="1"><italic toggle="yes">F</italic> = 19.26</td></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">p</italic> &lt; 0.00001</td></tr><tr><td rowspan="2" colspan="1">Males/females</td><td align="left" rowspan="2" colspan="1">99/125</td><td align="left" rowspan="2" colspan="1">40/51</td><td align="left" rowspan="2" colspan="1">42/36</td><td rowspan="1" colspan="1"><italic toggle="yes">χ</italic><sup>2</sup> = 106.04</td></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">p</italic> &lt; 0.00001</td></tr><tr><td rowspan="2" colspan="1">APOE ε4 carriers%</td><td rowspan="2" colspan="1">35.26%</td><td rowspan="2" colspan="1">70.32%</td><td rowspan="2" colspan="1">75.64%</td><td rowspan="1" colspan="1"><italic toggle="yes">χ</italic><sup>2</sup> = 155.6</td></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">p</italic> &lt; 0.00001</td></tr><tr><td rowspan="2" colspan="1">Years of education</td><td rowspan="2" colspan="1">12.87 (3.59)</td><td rowspan="2" colspan="1">12.48 (3.32)</td><td rowspan="2" colspan="1">12.50 (4.45)</td><td rowspan="1" colspan="1"><italic toggle="yes">F</italic> = 0.507</td></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">p</italic> = 0.603</td></tr><tr><td rowspan="2" colspan="1">ADAS-Cog delayed word recall</td><td rowspan="2" colspan="1">2.41 (1.71)</td><td rowspan="2" colspan="1">3.17 (1.96)</td><td rowspan="2" colspan="1">7.14 (2.20)</td><td rowspan="1" colspan="1"><italic toggle="yes">F</italic> = 184.7</td></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">p</italic> &lt; 0.00001</td></tr><tr><td rowspan="2" colspan="1">VOSP cube analysis</td><td rowspan="2" colspan="1">9.63 (0.85)</td><td rowspan="2" colspan="1">9.60 (1.12)</td><td rowspan="2" colspan="1">8.59 (2.27)</td><td rowspan="1" colspan="1"><italic toggle="yes">F</italic> = 18.89</td></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">p</italic> &lt; 0.00001</td></tr><tr><td rowspan="2" colspan="1">TMT (B–A) (seconds)</td><td rowspan="2" colspan="1">44.19 (27.06)</td><td rowspan="2" colspan="1">56.30 (52.14)</td><td rowspan="2" colspan="1">139.39 (109.87)</td><td rowspan="1" colspan="1"><italic toggle="yes">F</italic> = 74.23</td></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">p</italic> &lt; 0.00001</td></tr><tr><td rowspan="2" colspan="1">Global Aβ (SUVR)</td><td rowspan="2" colspan="1">0.47 (0.04)</td><td rowspan="2" colspan="1">0.65 (0.14)</td><td rowspan="2" colspan="1">0.78 (0.17)</td><td rowspan="1" colspan="1"><italic toggle="yes">F</italic> = 248.4</td></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">p</italic> &lt; 0.00001</td></tr><tr><td rowspan="2" colspan="1">Entorhinal tau (SUVR)</td><td rowspan="2" colspan="1">1.09 (0.12)</td><td rowspan="2" colspan="1">1.30 (0.26)</td><td rowspan="2" colspan="1">1.58 (0.37)</td><td rowspan="1" colspan="1"><italic toggle="yes">F</italic> = 133.1</td></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">p</italic> &lt; 0.00001</td></tr></tbody></table><table-wrap-foot><fn id="tblfn1"><p>Data are presented as mean values followed by (standard deviations). Demographic and clinical variables were compared between groups using ANOVA or <italic toggle="yes">χ</italic><sup>2</sup> tests. CU, cognitively unimpaired; MCI, mild cognitive impairment; APOE ε4, apolipoprotein E ε4 allele; ADAS, Alzheimer's Disease Assessment Scale–Cognitive Subscale; VOSP, Visual Object and Space Perception Battery; TMT (B–A), trail making test Part B–A; SUVR, standardized uptake value ratio. Note that a higher ADAS score indicates poor memory performance.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1.<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Participants’ characteristics</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><colgroup><col align="left"/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="left"/></colgroup><thead valign="bottom"><tr><th align="left" rowspan="2"/><th align="left">Aβ-negative CU</th><th align="left">Aβ-positive CU</th><th align="left">Aβ-positive MCI</th><th align="left" rowspan="2">Statistic</th></tr><tr><th align="left">N = 224</th><th align="left">N = 91</th><th align="left">N = 78</th></tr></thead><tbody valign="top"><tr><td rowspan="2">Age</td><td rowspan="2">65.41 (9.74)</td><td rowspan="2">69.97 (8.59)</td><td rowspan="2">71.97 (6.44)</td><td>F = 19.26</td></tr><tr><td>p &lt; 0.00001</td></tr><tr><td rowspan="2">Males/females</td><td align="left" rowspan="2">99/125</td><td align="left" rowspan="2">40/51</td><td align="left" rowspan="2">42/36</td><td>χ2 = 106.04</td></tr><tr><td>p &lt; 0.00001</td></tr><tr><td rowspan="2">APOE ε4 carriers%</td><td rowspan="2">35.26%</td><td rowspan="2">70.32%</td><td rowspan="2">75.64%</td><td>χ2 = 155.6</td></tr><tr><td>p &lt; 0.00001</td></tr><tr><td rowspan="2">Years of education</td><td rowspan="2">12.87 (3.59)</td><td rowspan="2">12.48 (3.32)</td><td rowspan="2">12.50 (4.45)</td><td>F = 0.507</td></tr><tr><td>p = 0.603</td></tr><tr><td rowspan="2">ADAS-Cog delayed word recall</td><td rowspan="2">2.41 (1.71)</td><td rowspan="2">3.17 (1.96)</td><td rowspan="2">7.14 (2.20)</td><td>F = 184.7</td></tr><tr><td>p &lt; 0.00001</td></tr><tr><td rowspan="2">VOSP cube analysis</td><td rowspan="2">9.63 (0.85)</td><td rowspan="2">9.60 (1.12)</td><td rowspan="2">8.59 (2.27)</td><td>F = 18.89</td></tr><tr><td>p &lt; 0.00001</td></tr><tr><td rowspan="2">TMT (B–A) (seconds)</td><td rowspan="2">44.19 (27.06)</td><td rowspan="2">56.30 (52.14)</td><td rowspan="2">139.39 (109.87)</td><td>F = 74.23</td></tr><tr><td>p &lt; 0.00001</td></tr><tr><td rowspan="2">Global Aβ (SUVR)</td><td rowspan="2">0.47 (0.04)</td><td rowspan="2">0.65 (0.14)</td><td rowspan="2">0.78 (0.17)</td><td>F = 248.4</td></tr><tr><td>p &lt; 0.00001</td></tr><tr><td rowspan="2">Entorhinal tau (SUVR)</td><td rowspan="2">1.09 (0.12)</td><td rowspan="2">1.30 (0.26)</td><td rowspan="2">1.58 (0.37)</td><td>F = 133.1</td></tr><tr><td>p &lt; 0.00001</td></tr></tbody></table></div>Data are presented as mean values followed by (standard deviations). Demographic and clinical variables were compared between groups using ANOVA or χ2 tests. CU, cognitively unimpaired; MCI, mild cognitive impairment; APOE ε4, apolipoprotein E ε4 allele; ADAS, Alzheimer's Disease Assessment Scale–Cognitive Subscale; VOSP, Visual Object and Space Perception Battery; TMT (B–A), trail making test Part B–A; SUVR, standardized uptake value ratio. Note that a higher ADAS score indicates poor memory performance.</transformed-table></extracted-table></extracted-tables-set>